Drug Trial Radar · NCT05068388
Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density
Last checked: Nov 19, 2026Latest source record: May 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
240
Actual
Start
Dec 21, 2021
Primary completion
Jun 14, 2024
Study completion Mar 12, 2026
Sponsor
- Lead sponsor
- Atossa Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 40 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-blinded, placebo-controlled dose-response efficacy study of oral (Z)-endoxifen in premenopausal women with measurable breast density. There will be 5 in-clinic visits (Screening, Day 1, Months 1, 3 and 6) and 3 self-report visits (Months 2, 4 and 5). Standard of care mammograms will be used for the screening mammogram as well as the 24-month follow up visit.
Conditions
- Breast Density
Interventions
Z-EndoxifenDrug
Z-Endoxifen
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of mammographic density area (cm2) assessed by iCAD® softwareTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Karma Study Centre
Stockholm, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.